Source: Annual Congress 2006 - Pulmonary hypertension: thromo-embolic processes
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Doughty, L. Sharples, J. Suntharalingam, D. Jenkins, J. Pepke-Zaba (Cambridge, United Kingdom). Impact of pulmonary endarterectomy (PEA) on quality of life as assessed by CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR). Eur Respir J 2006; 28: Suppl. 50, 2373

Member's Comments

No comment yet.

Related content which might interest you: The responsiveness and validity of the CAMPHOR Utility Index Source: Eur Respir J 2008; 32: 1513-1519 Year: 2008 Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Correlations between clinical variables and quality of life in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Responsiveness of the EQ-5D to Pulmonary Rehabilitation (PR) Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Effects of Pulmonary Rehabilitation (PR) on Exercise Capacity (EC) and Quality of Life (QOL) in Indian Patients with Severe COPD Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Is pulmonary endarterectomy (PEA) beneficial for the elderly? An analysis of quality of life (QoL) outcomes for older patients Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Prognostic value of outcome variables at follow-up in patients with PAH Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 The German version of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) – Four-stage translation and validation Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Reliability and validity of TAPQOL questionnaire for the assessment of global health related quality of life (HRQL) in children with Paediatric Central Airway Obstructive Disease (PCAOD) Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Physical activity (PA) in pulmonary arterial hypertension (PAH) can be predicted by questionnaire Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Asthma control (AC) and Quality of life (QoL) one year after Pulmonary Rehabilitation (PR) Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Evaluation of health related quality of life in patients under LTOT with the Severe Respiratory Insufficiency questionnaire (SRI) Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease Year: 2010 Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH). Source: International Congress 2017 – PAH and CTEPH Year: 2017 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013